Jul 7, 2025
Оfftopic Community
Оfftopic Community
Forums
New posts
Search forums
What's new
Featured content
New posts
New media
New media comments
New resources
New profile posts
Latest activity
Media
New media
New comments
Search media
Resources
Latest reviews
Search resources
Members
Current visitors
New profile posts
Search profile posts
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Install the app
Install
Forums
Information & News
RSS News
Health and Fitness
Relapses Reduced In Multiple Sclerosis Patients By New Oral Drug
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="tD33NAt" data-source="post: 2611615" data-attributes="member: 124445"><p>A new oral drug has been shown in a large international clinical trial to significantly reduce the relapse rate of people with multiple sclerosis and to slow the progression of the disease. The results of the Phase 3 trial of the drug teriflunomide were published in The New England Journal of Medicine. "This could be a safe, effective and convenient new therapy for multiple sclerosis,"said Dr. Paul O'Connor, the principal investigator for the study and director of the Multiple Sclerosis Clinic at St...<img src="http://feeds.feedburner.com/~r/mnt/healthnews/~4/eJdeqEJ9AZg" alt="" class="fr-fic fr-dii fr-draggable " data-size="" style="" /></p><p></p><p><a href="http://feedproxy.google.com/~r/mnt/healthnews/~3/eJdeqEJ9AZg/235639.php" target="_blank">More...</a></p></blockquote><p></p>
[QUOTE="tD33NAt, post: 2611615, member: 124445"] A new oral drug has been shown in a large international clinical trial to significantly reduce the relapse rate of people with multiple sclerosis and to slow the progression of the disease. The results of the Phase 3 trial of the drug teriflunomide were published in The New England Journal of Medicine. "This could be a safe, effective and convenient new therapy for multiple sclerosis,"said Dr. Paul O'Connor, the principal investigator for the study and director of the Multiple Sclerosis Clinic at St...[IMG]http://feeds.feedburner.com/~r/mnt/healthnews/~4/eJdeqEJ9AZg[/IMG] [url=http://feedproxy.google.com/~r/mnt/healthnews/~3/eJdeqEJ9AZg/235639.php]More...[/url] [/QUOTE]
Insert quotes…
Name
Verification
Please enable JavaScript to continue.
Loading…
Post reply
Top